Nemaura Medical

$5.13
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.07 (+1.38%) As of 3:07 PM UTC today

Why Robinhood?

You can buy or sell NMRD and other stocks, options, and ETFs commission-free!

About NMRD

Nemaura Medical, Inc. Common Stock, also called Nemaura Medical, is a holding company, which engages in the provision of medical device research. Through its subsidiaries, it manufactures and commercializes continuous glucose monitoring system, named sugarBEAT. The sugarBEAT is consist of a disposable adhesive skin-patch connected to a rechargeable wireless transmitter that displays glucose readings at regular five minute intervals with the use of a mobile app. The company was founded by Dewan Fazlul Hoque Chowdhury on December 24, 2013 and is headquartered in New York, NY. The listed name for NMRD is Nemaura Medical, Inc. Common Stock.

CEO
Dewan Fazlul Hoque Chowdhury
Employees
17
Headquarters
New York, New York
Founded
2013
Market Cap
110.42M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
91.93K
High Today
$5.40
Low Today
$5.10
Open Price
$5.31
Volume
20.35K
52 Week High
$16.50
52 Week Low
$2.50

Collections

NMRD Earnings

-$0.07
-$0.05
-$0.02
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
— per share
Actual
Expected Feb 17, Pre-Market

You May Also Like

ABG
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure